Key facts
- This page summarizes Christos Kaskavelis's Form 4/A - Amendment filing for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Apr 2023, 16:47.
Key filing fact
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents 345,794 restricted stock units that is a contingent right to receive common stock upon vesting granted pursuant to the Advent Technologies Holdings, Inc. 2021 Equity Incentive Plan, dated as of February 4, 2021. The restricted stock units will vest 25% upon each anniversary of February 4, 2021, the vesting commencement date, until the fourth anniversary of the vesting commencement date.
Footnote F2
Reflects shares of Issuer's common stock beneficially owned through Nemaland Ltd.
SEC remarks
This Form 4A amends and restates Table I of the Form 4 filed June 15, 2021, which inadvertently incorrectly stated the Reporting Person's aggregate shares of common stock owned directly and indirectly following the grant reported on such Form 4.